PFE
Dividend, but make it marathon mode
Pfizer said its board declared a $0.43 second-quarter 2026 dividend on common stock, payable June 12, 2026 to shareholders of record on May 8, 2026. That makes this the company’s 350th consecutive quarterly dividend — which is basically the corporate version of showing up to brunch every Sunday for 87 years.
Why investors should care
For dividend investors, this is the kind of news that says, “Relax, the check is still in the mail.” Pfizer has spent years trying to balance growth, patent pressure, and all the usual pharma chaos, but the payout remains part of the pitch.
- Quarterly payout: $0.43 per share
- Payable: June 12, 2026
- Record date: May 8, 2026
- Streak: 350 straight quarterly dividends
The bigger picture
This isn’t a moonshot catalyst, but it does matter if you own PFE for income. A steady dividend can help cushion the stock when the pipeline gets noisy or the market decides to be moody for no reason.
Big picture: Pfizer is still leaning into its identity as a cash-returning giant, even while it juggles the more glamorous — and riskier — parts of the pharma business.